Clinical Trial

A Exploratory Study of NatureU Sweet Dream on Sleep Outcomes

Study acronym: NUSD
Completed
View on ClinicalTrials.gov →
Summary
This was a single-center, open-label, exploratory self-controlled study evaluating NatureU Sweet Dream on sleep outcomes in adults with mild to moderate sleep disturbance. Seventeen participants were enrolled, 2 participants were lost to follow-up, and 15 participants provided valid effectiveness data. Participants completed two independent test-food sessions using wearable sleep monitoring. The comparator session used a commercially available melatonin product, and the test-product session used NatureU Sweet Dream. The main outcomes were deep sleep duration and deep sleep percentage measured by a wearable device and exported through the Huawei Health application. No adverse reactions were reported during the study.
Trial Details
NCT Number NCT07600528
Lead Sponsor OmniSolutions Laboratory Holdings Limited
Conditions Sleep Disturbance, Sleep Quality
Enrollment 17 participants
Start Date 2024-04-15
Primary Completion 2024-04-17 (estimated)
Study Completion 2024-04-17 (estimated)
Updated on ClinicalTrials.gov 2026-05-20